DK108571C - Fremgangsmåde til fremstilling af 17-hydroxy-, acyloxy- eller alkoxy-20-oxo-10α-methylsteroider af pregnanrækken. - Google Patents

Fremgangsmåde til fremstilling af 17-hydroxy-, acyloxy- eller alkoxy-20-oxo-10α-methylsteroider af pregnanrækken.

Info

Publication number
DK108571C
DK108571C DK362761AA DK362761A DK108571C DK 108571 C DK108571 C DK 108571C DK 362761A A DK362761A A DK 362761AA DK 362761 A DK362761 A DK 362761A DK 108571 C DK108571 C DK 108571C
Authority
DK
Denmark
Prior art keywords
acyloxy
oxo
alkoxy
hydroxy
preparation
Prior art date
Application number
DK362761AA
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of DK108571C publication Critical patent/DK108571C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
DK362761AA 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 17-hydroxy-, acyloxy- eller alkoxy-20-oxo-10α-methylsteroider af pregnanrækken. DK108571C (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL226774 1958-04-12
NL232312 1958-10-15
NL236884 1959-03-07

Publications (1)

Publication Number Publication Date
DK108571C true DK108571C (da) 1968-01-08

Family

ID=27351008

Family Applications (7)

Application Number Title Priority Date Filing Date
DK362761AA DK108571C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 17-hydroxy-, acyloxy- eller alkoxy-20-oxo-10α-methylsteroider af pregnanrækken.
DK363061AA DK103510C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 3-oxo-Δ<1>-10α-methylsteroider af androstanrækken eller af pregnanrækken.
DK363161AA DK107871C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 2-alkyl-3-oxo-10α-methylsteroider af androstan- eller pregnanrækken.
DK126859AA DK110201C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 10α-methyl-9β-steroidforbindelser af pregnanrækken.
DK362661AA DK118503B (da) 1958-04-12 1961-09-12 Fremgangsmåde til fremstilling af 21-hydroxy- eller -acyloxy-9β 10α-steroider af pregnanrækken.
DK362961AA DK124079B (da) 1958-04-12 1961-09-12 Fremgangsmåde til fremstilling a 3-oxo-Δ<4,6>-9β, 10α-steroider af androstanrækken eller pregnanrækken.
DK481862AA DK115038B (da) 1958-04-12 1962-11-08 Fremgangsmåde til fremstilling af 9β,10α-methylsteroider af androstanrækken.

Family Applications After (6)

Application Number Title Priority Date Filing Date
DK363061AA DK103510C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 3-oxo-Δ<1>-10α-methylsteroider af androstanrækken eller af pregnanrækken.
DK363161AA DK107871C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 2-alkyl-3-oxo-10α-methylsteroider af androstan- eller pregnanrækken.
DK126859AA DK110201C (da) 1958-04-12 1959-04-11 Fremgangsmåde til fremstilling af 10α-methyl-9β-steroidforbindelser af pregnanrækken.
DK362661AA DK118503B (da) 1958-04-12 1961-09-12 Fremgangsmåde til fremstilling af 21-hydroxy- eller -acyloxy-9β 10α-steroider af pregnanrækken.
DK362961AA DK124079B (da) 1958-04-12 1961-09-12 Fremgangsmåde til fremstilling a 3-oxo-Δ<4,6>-9β, 10α-steroider af androstanrækken eller pregnanrækken.
DK481862AA DK115038B (da) 1958-04-12 1962-11-08 Fremgangsmåde til fremstilling af 9β,10α-methylsteroider af androstanrækken.

Country Status (13)

Country Link
US (4) US3192201A (da)
AT (2) AT281307B (da)
CH (14) CH430710A (da)
CS (2) CS161826B2 (da)
DE (1) DE1253707B (da)
DK (7) DK108571C (da)
ES (1) ES248593A1 (da)
FI (2) FI42083B (da)
FR (1) FR953M (da)
GB (5) GB929277A (da)
NO (1) NO122835B (da)
OA (1) OA02640A (da)
SE (9) SE342814B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH430710A (de) * 1958-04-12 1967-02-28 Philips Nv Verfahren zur Herstellung neuer Steroide
BE634693A (da) * 1962-07-10
US3235573A (en) * 1962-12-20 1966-02-15 Syntex Corp 19-lower alkylidene and 19-oxo-delta4-androsten-17beta-ol-3-one derivatives
NL123937C (da) * 1963-11-06
US3463852A (en) * 1966-01-14 1969-08-26 Schering Corp Treating allergies with steroids of the pregnane series
CH476711A (de) * 1966-06-10 1969-08-15 Hoffmann La Roche Verfahren zur Herstellung von neuen 9B,10a-Steroiden
GB1266361A (da) * 1969-07-16 1972-03-08
US5922699A (en) 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
CN113880904B (zh) * 2020-07-01 2024-04-12 苏州朗科生物技术股份有限公司 合成地屈孕酮的新方法及化合物
CN114057820B (zh) * 2021-11-15 2023-06-27 湖南科瑞生物制药股份有限公司 一种地屈孕酮的精制方法
CN114957370B (zh) * 2021-12-06 2023-09-19 湖南醇康医药科技有限公司 一种地屈孕酮的制备和纯化方法
CN114957369B (zh) * 2021-12-07 2023-10-31 湖南醇康医药科技有限公司 一种地屈孕酮的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE882399C (de) * 1937-11-28 1953-07-09 Schering Ag Verfahren zur Darstellung von 17-AEthinyl-?-androstenol-17-on-3 und dessen Derivaten
US2752337A (en) * 1951-06-28 1956-06-26 Upjohn Co Steroid enamines
US2739974A (en) * 1953-04-06 1956-03-27 Searle & Co Process of preparing delta4,6-3-ketosteroids
US2871245A (en) * 1956-06-19 1959-01-27 Ciba Pharm Prod Inc New 1-dehydro-testosterones and esters thereof
US2867630A (en) * 1958-06-09 1959-01-06 Upjohn Co 6-fluoro androstenes
CH430710A (de) * 1958-04-12 1967-02-28 Philips Nv Verfahren zur Herstellung neuer Steroide
GB956691A (en) * 1961-10-05 1964-04-29 British Drug Houses Ltd 3-unsubstituted-í¸-androstene compounds

Also Published As

Publication number Publication date
SE341401B (da) 1971-12-27
DK107871C (da) 1967-07-17
CH464183A (de) 1968-10-31
AT281307B (de) 1970-05-25
CS149567B2 (da) 1973-07-25
SE341398B (da) 1971-12-27
CH415613A (de) 1966-06-30
FR953M (da) 1961-11-27
NO122835B (da) 1971-08-23
CS161826B2 (da) 1975-06-10
CH432505A (de) 1967-03-31
CH416612A (de) 1966-07-15
DK103510C (da) 1966-01-17
FI42083B (da) 1970-02-02
FI42212B (da) 1970-03-02
CH430710A (de) 1967-02-28
OA02640A (fr) 1970-12-15
GB929277A (en) 1963-06-19
CH434244A (de) 1967-04-30
CH415615A (de) 1966-06-30
GB929271A (en) 1963-06-19
US3192201A (en) 1965-06-29
CH415614A (de) 1966-06-30
DK118503B (da) 1970-08-31
US3362968A (en) 1968-01-09
SE341400B (da) 1971-12-27
DE1253707B (de) 1967-11-09
CH432506A (de) 1967-03-31
US3445489A (en) 1969-05-20
DK110201C (da) 1970-11-30
ES248593A1 (es) 1959-11-16
CH420131A (de) 1966-09-15
GB929276A (en) 1963-06-19
DK115038B (da) 1969-09-01
CH428720A (de) 1967-01-31
SE341399B (da) 1971-12-27
CH441299A (de) 1967-08-15
SE342814B (da) 1972-02-21
CH455765A (de) 1968-05-15
GB929279A (en) 1963-06-19
US3373172A (en) 1968-03-12
AT287213B (de) 1971-01-11
DK124079B (da) 1972-09-11
SE342445B (da) 1972-02-07
CH420130A (de) 1966-09-15
GB929278A (en) 1963-06-19
SE341848B (da) 1972-01-17
SE341397B (da) 1971-12-27
SE341394B (da) 1971-12-27

Similar Documents

Publication Publication Date Title
DK108571C (da) Fremgangsmåde til fremstilling af 17-hydroxy-, acyloxy- eller alkoxy-20-oxo-10α-methylsteroider af pregnanrækken.
DK116207B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-steroider af pregnanrækken.
DK118874B (da) Fremgangsmåde til fremstilling af 9α,11β-dihalogensteroider af pregnan- eller androstanrækken.
DK119156B (da) Fremgangsmåde til fremstilling af 6α-methyl-16-methylen-steroider af pregnanrækken.
DK110013C (da) Fremgangsmåde til fremstilling af 17α-hydroksy-16-metylenpregn-4-en-3,20-dion.
DK100293C (da) Fremgangsmåde til fremstilling af 10α-methylsteroider af androstanrækken.
DK90176C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-3-keto-6-methyl-steroidforbindelser af androstan- eller pregnanrækken.
DK94042C (da) Fremgangsmåde til fremstilling af 17β-hydroksy-17α-alkynylsteroider af androstanrækken.
DK93675C (da) Fremgangsmåde til fremstilling af 21-fluor-9α-halogen-11β-hydroxy-steroider af pregnanrækken.
DK117350B (da) Fremgangsmåde til fremstilling af 11β-hydroxy-17α-acyloxy-steroider af pregnan-rækken.
DK95938C (da) Fremgangsmåde til fremstilling af estere af 17α-hydrosky-6α-metyl-16-metylen-4-pregnen-3,20-dion.
DK118875B (da) Fremgangsmåde til fremstilling af 17α-hydroxy-16-alkylen-steroider.
DK107290C (da) Fremgangsmåde til fremstilling af 16-methylen-steroider.
DK100613C (da) Fremgangsmåde til fremstilling af 17α-halogenethinylsteroider af androstan- eller 19-nor-androstandrækken.
DK89185C (da) Fremgangsmåde til fremstilling af 17α,21-dihydroxy-20-keto-steroider af pregnanrækken.
DK92964C (da) Fremgangsmåde til fremstilling af 6,7-dihalogen-methylenderivater af androstan- eller pregnanrækken.
DK96786C (da) Fremgangsmåde til fremstilling af 4-methyl-3-oxo-Δ&lt;4&gt;-steroider.
DK90175C (da) Fremgangsmåde til fremstilling af tiocyanhydriner af steroidrækken.
DK107226C (da) Fremgangsmåde til fremstilling af 19-oxygenerede steroider.
DK99405C (da) Fremgangsmåde til fremstilling af Schiff-baser af steroider af androstan- eller 19-nor-androstanrækken.
DK108138C (da) Fremgangsmåde til fremstilling af 16α-methyl-11β, 17 α, 21-trihydroxy-4-pergnen-3, 20-dion.
DK94265C (da) Fremgangsmåde til fremstilling af S-substituerede 4-thiomethyl-3-oxo-Δ&lt;4&gt;-steroider.
DK105643C (da) Fremgangsmåde til fremstilling af 3-keto-Δ&lt;4,6&gt;-10α-methylsteroider.
DK94990C (da) Fremgangsmåde til fremstilling af 3-keto-Δ&lt;5&gt;-steroider af pregnan- eller androstan-rækken.
DK93734C (da) Fremgangsmåde til fremstilling af A-nor-4-pregnen-3,20-dioner.